Caprelsa® (vandetanib) is a medicine that is used in adults and children above 5 years of age to treat aggressive and symptomatic medullary thyroid cancer 1. This is a new step forward in ESTEVE ...

Medullary thyroid carcinoma is a type of cancer that starts in the cells in the thyroid gland that produces the hormone calcitonin.

Researchers conducted a retrospective cohort study to assess the predictive value of molecular profiling on thyroid tumor behavior.

Updated thresholds outperform those recommended by American Thyroid Association guidelines for patients with medullary thyroid cancer.

Thyroid. 2003;13 (1) Follow-up of Patients with Deferred FNA The follow-up frequency (i.e. every 6 to 24 months) should be appropriate for the degree of diagnostic certainty that the nodule is benign.